Approximately one in every five adults1 have sleep-disordered breathing (SDB).
An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health.
Through its strong partnership with the global medical community, ResMed is committed to:
- increasing awareness of the dangers of untreated SDB
- supporting ongoing research into the correlation of SDB with other health risks
- finding effective clinical solutions to improve the health and lives of SDB patients.
We are currently supporting and actively engaged in research initiatives in the following five associated areas of clinical focus:
- Cardiovascular diseases
- Chronic Obstructive Pulmonary Disease (overlap syndrome)
- Type 2 diabetes
- Occupational health and safety
- Peri-operative care
Learn more about ResMed’s research and development initiatives in the five areas of clinical focus.
You can also read a selection of recently published clinical articles, about:
- Autoset
- Bariatrics
- Cardiovascular
- Compliance
- Diabetes
- Farrell Favourites
- NIV/NPPV
- SDB and CPAP
- Traffic Accidents